Karin Jooss
Vermögen: 27 968 $ am 31.05.2026
Vermögen: 27 968 $ am 31.05.2026
Karin Jooss is currently an Independent Director at Fate Therapeutics, Inc. since 2019.
Former positions include Executive VP & Head-Research & Development at Nexoplex Bio, Inc. from 2021 to 2024, Head-Cancer Immunotherapeutics at Pfizer Inc. from 2009 to 2016, and Vice President-Research at Cell Genesys, Inc. from 2005 to 2009.
Education includes a doctorate from Philipps University of Marburg.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FATE THERAPEUTICS, INC. 0,01 % | 12.06.2026 | 9.848 ( 0,01 % ) | 27 968 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| FATE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 14.03.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| GRITSTONE BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2024 |
| PFIZER INC. | Corporate Officer/Principal | 01.04.2016 |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2009 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Gritstone bio, Inc.
Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen